
|Podcasts|September 15, 2022
From Persia To Precision Medicine
Author(s)Elaine Quilici, Miranda Schmalfuhs
Advertisement
In episode 117, Helen Sabzevari, CEO of Precigen, discusses her drive to study science as a Persian-born woman, the opportunities she’s had to research immunology, and how she’s now developing next-generation CAR-T treatments for cancer, in addition to other therapies.
This podcast sponosored by
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Amplitude Therapeutics, Chai Discovery Enter Collaborations with Eli Lilly, Bristol Myers Squibb
2
Who Pays for Tariff Driven Input Cost Increases?
3
Pharmaceutical Executive Daily: Amplitude Therapeutics Partners with Eli Lilly
4
The Shift Towards Globally Sourced Innovation
5
